About HemoCleanse

Home

About Us

News

Services

Products

Companies

Investors Only

Resources

Contact Us

(c) HemoCleanse, Inc.

About Us

HemoCleanse has an extensive history of research and product development of innovative medical technologies, particularly in sorbent-based extracorporeal therapies and vascular access systems for use with other extracorporeal therapies.

Areas of focus have been and continue to be:

Liver disease, including hepatitis

Drug overdose

Sepsis

Autoimmune diseases, including lupus, rheumatoid arthritis, ...

Kidney disease

We function as a product R&D firm, with a continual stream of products in the pipeline, creating subsidiaries and spin-offs to nurture these products as they mature. A core function of HemoCleanse is relationship-building with other researchers, clinicians, and medical companies who are on the cutting edge of extracorporeal technologies.

Please take a minute to explore our corporate profile:

We invite you also to explore these links throughout our site:

Thank you for taking the time to visit. We look forward to a lasting relationship with patients, physicians, caregivers, insurers, investors, foundations and partners who derive benefit from our innovative research and development.

Don't miss
More
Big News!

HemoCleanse gets $1M grant to advance its technology into treating bioterror-related sepsis!

Check out the underlying technology.